Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

Completed · Phase 2

Conditions studied: Acute Bacterial Corneal Ulcers, Bacterial Keratitis

In brief

This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers

Key facts

Study ID

NCT00651586

Run by

Allergan

People needed

129

Starts

2003-10-01

Expected to finish

2005-04-01

Last updated by the study team

2008-07-29

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis in one eye only of an acute bacterial corneal ulcer (>1mm)

You may not qualify if…

• Corneal ulcer that in the opinion of the investigator had to be treated with fortified antibiotics, or multiple antibiotics, or anti-infectives other than study medication

Where it is running

• Study site — Galveston, Texas, United States
• Study site — Madurai, Tamil Nadu, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.